Symbol
| ASAH1
| contributors: mct/pgu - updated : 03-07-2018
|
HGNC name
| N-acylsphingosine amidohydrolase (acid ceramidase) 1
|
HGNC id
| 735
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in prostate carcinoma | |
Susceptibility
|
to adult SMA phenotype with no myoclonic epilepsy |
Variant & Polymorphism
SNP
| association between ASAH1 variants and an adult SMA phenotype with no myoclonic epilepsy nor death in early age |
|
|
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | reproductive | breast | |
expression correlates with a better prognosis in ER-positive breast cancer | cancer | reproductive | prostate | |
critical regulator of prostate cancer progression by affecting tumor cell proliferation and migration and also responses to drug therapy, suggesting ASAH1 as a potential therapy target in advanced PCa |
| | | |